Raw material and freight cost escalation
Geopolitical tensions in West Asia have increased raw material, packaging, and freight costs; management noted uncertainty in passing these on to customers.
GRANULESINDIA / bear-case history
Track the concerns that keep returning.
Granules India · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
high
Gagilapur FDA reinspection timeline uncertainty
Despite completing remediation, the FDA has not scheduled a reinspection; management cannot estimate when it will occur, delaying potential product launches.
Peptide CDMO customer concentration and project dependency
The peptide CDMO business is project-driven with potential quarter-to-quarter volatility; management declined to disclose order book or customer concentration details.
DCDA project commercialization delays
The DCDA pilot plant faced pricing pressure from Chinese competitors; commercialization may be delayed by 2-3 months, with capex of ~₹200 crore.